Humacyte, Inc. (HUMA)
1.13
-0.02
(-1.74%)
USD |
NASDAQ |
Feb 20, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Humacyte Profit Margin (Quarterly) : -2.33K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 34.40% |
| Hims & Hers Health, Inc. | 2.63% |
| Becton, Dickinson & Co. | 7.27% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -30.48% |
| Return on Invested Capital | -84.37% |
| Gross Profit Margin (Quarterly) | -182.2% |
| Operating Margin (Quarterly) | -3.24K% |
| Return on Net Operating Assets | -81.56% |